Nav: Home

Current Lymphoma News and Events

Current Lymphoma News and Events, Lymphoma News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers. (2020-07-09)
Most American women haven't heard of breast implant-related lymphoma
Only about 1 out 7 American women have heard about breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) -- an immune system cancer occurring in a small percentage of women with breast implants, according to a new survey. (2020-06-25)
A metabolic enzyme drives lymphoma and is a potential drug target
Scientists at the Sloan Kettering Institute have found that increased activity of a normal metabolic enzyme can lead to cancer. (2020-06-24)
Early clinical trial supports tumor cell-based vaccine for mantle cell lymphoma
A phase I/II clinical trial by researchers at Stanford University suggests that vaccines prepared from a patient's own tumor cells may prevent the incurable blood cancer mantle cell lymphoma (MCL) from returning after treatment. (2020-06-19)
The novel mechanisms for inflammation and cancer induced by HTLV-1
A Japanese research group has clarified the mechanism by which human T-cell leukemia virus type 1 (HTLV-1) causes inflammation and oncogenesis. (2020-06-16)
A new immunotherapeutic agent for children and adolescents with advanced lymphoma
The excellent results of the phase III international paediatric study, Inter-B-NHL ritux 2010, have been published in the New England Journal of Medicine. (2020-06-03)
Phase III results show rituximab excels against pediatric Burkitt lymphoma
Results of the phase III Inter-B-NHL-ritux 2010 clinical trial reported today in the New England Journal of Medicine show 95 percent three-year survival for pediatric patients with advanced B-cell non-Hodgkin lymphoma treated with the addition of anti-cancer immunotherapy rituximab to standard chemotherapy. (2020-06-03)
Publication in Nature Communications highlights the preclinical development of SYNB1891
Synlogic today announced the publication in Nature Communications of preclinical data supporting its first clinical immuno-oncology program, SYNB1891, which is being evaluated in a Phase 1 clinical trial in patients with advanced solid tumors or lymphoma. (2020-06-01)
The fight goes on: Clinical trial shows promising new treatment for rare blood cancer
Although lymphoma is one of the most common types of blood cancer, it has a rare subtype for which no effective treatment regimens are known. (2020-05-30)
Cancer drugs cause large cells that resist treatment; scientist aims to stop it
Fueled by genetic changes due to cancer therapy itself, rogue cells may become very large with twice or quadruple the number of chromosomes found in healthy cells. (2020-05-28)
Study confirms effective, less toxic treatment option for adults with Burkitt lymphoma
In a new study, an alternative treatment regimen that is less toxic than standard dose-intensive chemotherapy was found to be highly effective for adults with Burkitt lymphoma across all age groups and independent of HIV status. (2020-05-26)
Moffitt Cancer Center study suggests more could benefit from CAR T-cell therapy
Moffitt Cancer Center organized a consortium of 16 cancer treatment facilities across the US that offer Yescarta as a standard-of-care therapy for patients with relapsed/refractory large B cell lymphoma. (2020-05-14)
A new therapeutic target turns the immune system against lymphoma
EPFL scientists have identified a key mechanism that tumor cells use to take advantage of and avoid detection from the immune system. (2020-04-23)
Is it bloating or is it a heart attack?
A patient in the hospital for metastatic Hodgkin lymphoma with significant abdominal distention displayed sudden onset of ST-segment elevations -- often an indicator of a heart attack -- however the heart attack symptoms improved when the cardiovascular care team pressed on the abdomen during a standard exam, according to a case published in JACC: Case Reports. (2020-04-15)
Lymphoma's different route revealed
Researchers at the MDC observe the very early stages of blood vessel development in lymph node tumors. (2020-04-07)
Majority of patients responded in CAR T-cell trial for mantle cell lymphoma
Majority of patients responded in CAR T-cell trial for mantle cell lymphoma. (2020-04-01)
Certain cancers come with higher risk of serious heart rhythm disorder
People with a history of cancer have an over two-fold risk of developing atrial fibrillation (AFib), the most common heart rhythm disorder, compared to the general population, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC). (2020-03-18)
Cancer survival rates improve for young adults
A new study in the Journal of the National Cancer Institute finds improvements in five-year survival rates for all cancers in young adults. (2020-03-03)
Five-year survival improves for certain cancers in adolescent and young adults
The five-year survival rate for adolescents and young adults with cancer has significantly improved from 1975 to 2005 in the United States overall, but this was not the case for all cancers, according to a report in the Journal of the National Cancer Institute. (2020-03-03)
Old weapon, new target: Dasatinib against angioimmunoblastic T-cell lymphoma
Researchers from the University of Tsukuba have shown by in vivo experimentation on a mouse model that angioimmunoblastic T-cell lymphoma is highly dependent on T-Cell Receptor Signaling. (2020-02-28)
CNIO and Cabimer researchers show that DNA topological problems may cause lymphoma
Movements and changes in 3D genome structure form knots and tangles in the DNA. (2020-02-24)
New front opened in fight against common cancer driver
Australian researchers have revealed a new vulnerability in lymphomas that are driven by one of the most common cancer-causing changes in cells. (2020-02-20)
New study finds cellular immunotherapy treatment associated with improved quality of life
Adult lymphoma patients whose disease was effectively treated with chimeric antigen receptor T-cell (CAR-T) therapy showed marked improvement on a variety of self-reported quality of life measures, according to a study published today in Blood Advances. (2020-02-19)
A randomized, double-blind trial of F14512, a polyamine-vectorized anticancer drug, compared...
The objective of this study was to compare the safety and antitumor activity of F14512 and etoposide phosphate in dogs with spontaneous non-Hodgkin lymphoma and to investigate the potential benefit of F14512 in P-glycoprotein overexpressing lymphomas. (2020-02-19)
Cancer immunotherapy target helps fight solid tumors
Yvonne Chen engineers immune cells to target their most evasive enemy: cancer. (2020-02-15)
Radiation therapy to heart can worsen fatigue, shortness of breath in cancer patients
Radiation doses to the heart that occur during radiation therapy treatments for lung cancer, breast cancer and lymphoma can increase fatigue, cause difficulty breathing and lower capacity for physical activity in patients with cancer, according to research presented at the American College of Cardiology's Advancing the Cardiovascular Care of the Oncology Patient course. (2020-02-14)
Research pinpoints rogue cells at root of autoimmune disease
Breakthrough cellular genomics technology has allowed Garvan and UNSW Sydney researchers to reveal genetic mutations causing rogue behaviour in the cells that cause autoimmune disease. (2020-02-13)
Suspect eliminated as a therapeutic target in B cell lymphoma
Australian researchers have narrowed the focus on which survival proteins are important for the survival of B cell lymphomas, eliminating the protein BCL-W from the 'suspect list'. (2020-02-04)
Discovery could lead to new treatment for rare blood disease
A new study shows cancer cells found in the lesions on the skin of cutaneous T-cell lymphoma patients originate from the blood, not the skin as was believed. (2020-01-27)
Male fertility after chemotherapy: New questions raised
Professor Delbès, who specializes in reproductive toxicology, conducted a pilot study in collaboration with oncologists and fertility specialists from the McGill University Health Centre (MUHC) on a cohort of 13 patients, all survivors of pediatric leukemia and lymphoma. (2020-01-22)
AI Therapeutics announces that a common LAM-002 mechanism in cancer and neurodegenerative diseases shows antitumor activity in the clinic and hope for ALS
AI Therapeutics has made significant recent progress with its four clinical assets and proprietary Guardian Angel™ algorithm. (2020-01-16)
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas. (2020-01-08)
Treatment with PD-1 prior to stem cell transplant is safe for Hodgkin lymphoma patients
A new analysis shows that a donor stem cell transplant following treatment with an immune checkpoint inhibitor is generally safe and produces good outcomes for patients with Hodgkin lymphoma. (2019-12-09)
CAR T-cell therapy effective for relapsed mantle cell lymphoma patients
A one-year follow-up study revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) . (2019-12-09)
No radiation needed for many aggressive non-Hodgkin's lymphoma patients
Most people diagnosed with the most common type of non-Hodgkin's lymphoma can safely skip radiation treatment after a clear PET scan, according to new clinical trial results released today at the 61st American Society of Hematology (ASH) Annual Meeting. (2019-12-08)
Follicular lymphoma remission for 2+ years indicates disease-free status could be lifelong
People with follicular lymphoma, a slow-growing lymphatic-system cancer, who have been treated and are in remission for at least two years, may no longer have what has been considered an incurable disease based on highly sensitive testing; this means they no longer need therapy or active follow-up. (2019-12-08)
Lymphoma patients may have new path to remission, even when CAR T therapy fails
A new, experimental immunotherapy can put patients with B-cell non-Hodgkin lymphoma (NHL) that is resistant to or has come back after multiple other therapies, including CAR T therapy, into remission. (2019-12-07)
Leukemia, lymphoma squarely in sights of new class of drugs
A new class of drugs degrades an essential survival protein in cancer cells while sparing platelets. (2019-12-06)
Exploring drug repurposing to treat glioblastoma
MALT1 blockers have long been in clinical use for the treatment of blood cancers. (2019-11-27)
Radiation from CT scans associated with increased risk for cancer
A new study in JNCI Cancer Spectrum finds that exposure to radiation from CT scans is associated with higher risks of developing thyroid cancer and leukemia. (2019-11-19)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Making Amends
What makes a true apology? What does it mean to make amends for past mistakes? This hour, TED speakers explore how repairing the wrongs of the past is the first step toward healing for the future. Guests include historian and preservationist Brent Leggs, law professor Martha Minow, librarian Dawn Wacek, and playwright V (formerly Eve Ensler).
Now Playing: Science for the People

#565 The Great Wide Indoors
We're all spending a bit more time indoors this summer than we probably figured. But did you ever stop to think about why the places we live and work as designed the way they are? And how they could be designed better? We're talking with Emily Anthes about her new book "The Great Indoors: The Surprising Science of how Buildings Shape our Behavior, Health and Happiness".
Now Playing: Radiolab

The Third. A TED Talk.
Jad gives a TED talk about his life as a journalist and how Radiolab has evolved over the years. Here's how TED described it:How do you end a story? Host of Radiolab Jad Abumrad tells how his search for an answer led him home to the mountains of Tennessee, where he met an unexpected teacher: Dolly Parton.Jad Nicholas Abumrad is a Lebanese-American radio host, composer and producer. He is the founder of the syndicated public radio program Radiolab, which is broadcast on over 600 radio stations nationwide and is downloaded more than 120 million times a year as a podcast. He also created More Perfect, a podcast that tells the stories behind the Supreme Court's most famous decisions. And most recently, Dolly Parton's America, a nine-episode podcast exploring the life and times of the iconic country music star. Abumrad has received three Peabody Awards and was named a MacArthur Fellow in 2011.